CapsoVision, Inc. Common Stock (CV) Stock Price
CVStock
$6.53+41.65%52W
Market Cap$347.46M
P/E—
PEG Ratio—
Div yield—
Beta-2.02
CV Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-8.51%
Price vs S&P 500 (4W)6.82%
VGM Score34.46
CV Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.13 | -$0.15 | -15.38%(-$0.02) | |
| Q1 2026 | -$0.13 | -$0.15 | -15.38%(-$0.02) | |
| Q4 2025 | -$0.14 | -$0.16 | -8.83%(-$0.01) | |
| Q3 2025 | -$0.13 | -$0.17 | -36.00%(-$0.05) | |
| Q2 2025 | -$0.11 | -$0.10 | +10.09%(+$0.01) |
CV Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.22
4.22
4.22
4.20
Industry Peers — Electromedical Equipment(31)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
CVCapsoVision, Inc. Common Stock | F | D | B | 25.0x | — | 50.9% | -217.1% | $6.53 |
| MDTMedtronic plc | B | C | B | 3.2x | 3.8% | 65.7% | 18.1% | $94.75 |
| ITGRInteger Holdings Corporation | C | C | A | 2.3x | 11.6% | 26.1% | 9.7% | $126.70 |
| LIVNLivaNova PLC Ordinary Shares | C | B | B | 2.9x | 8.2% | 68.1% | 12.5% | $77.58 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | D | 3.7x | 88.2% | 58.7% | 12.2% | $70.78 |
| AXGNAxogen, Inc. Common Stock | F | B | B | 8.1x | 14.9% | 74.6% | -11.8% | $34.62 |
| BLFSBioLife Solutions Inc. | F | C | A | 18.4x | 14.9% | 63.9% | 2.9% | $38.61 |
| CNMDCONMED Corporation | B | C | B | 1.0x | 9.8% | 55.8% | 8.0% | $46.72 |
| CBLLCeriBell, Inc. Common Stock | F | A | A | 9.4x | — | 88.9% | -68.6% | $25.04 |
| INMDInMode Ltd. Ordinary Shares | A | D | C | 2.2x | 12.4% | 76.5% | 18.5% | $14.16 |
| ELMDElectromed, Inc. | C | B | C | 3.1x | 15.6% | 78.5% | 18.8% | $27.42 |
About CapsoVision, Inc. Common Stock
CapsoVision develops ingestable capsule endoscopy technology for gastrointestinal imaging, enabling earlier detection of colorectal cancer and other GI diseases. The company's platform features multi-camera capsules with LED illumination, onboard memory, and extended battery life for comprehensive visualization. Current commercial product CapsoCam Plus targets the small intestine, while CapsoColon 3D is in development for large intestine imaging.